Climate Change Data

Pharmarise HDS

Climate Impact & Sustainability Data (2022, FY2018/05 to FY2024/05)

Reporting Period: 2022

Environmental Metrics

ESG Focus Areas

  • Sustainability
  • Human Capital
  • Diversity & Inclusion

Social Achievements

  • Increased percentage of mid-career hires in managerial positions to 86% in FY2022.
  • Set a target of 30% women in managerial positions by FY2026.

Governance Achievements

  • Established a Sustainability Committee in June 2021.
  • Established a Sustainability Policy in May 2022.
  • Aims to declare support for the TCFD recommendations.
  • Established a Nomination and Remuneration Committee.

Climate Goals & Targets

Medium-term Goals:
  • 30% women in managerial positions by FY2026

Environmental Challenges

  • Determining materiality (material issues) and measures to address them in sustainability.
  • Calls for disclosure of appropriate action to address social and environmental issues and other sustainability issues.
Mitigation Strategies
  • Sustainability Committee working with outside consultants to manage GHG emissions data, understand current status, and consider setting targets.
  • Plans to make disclosures about its sustainability initiatives with the help of an outside consultant.
  • Continuously focusing on enhancing and improving information provision, striving for livelier deliberations at meetings of the Board of Directors and continuing to increase the effectiveness of the Board of Directors as a whole.

Supply Chain Management

Climate-Related Risks & Opportunities

Reporting Standards

Frameworks Used: TCFD

Reporting Period: FY2018/05 to FY2024/05

Environmental Metrics

Total Carbon Emissions:Not disclosed
Scope 1 Emissions:Not disclosed
Scope 2 Emissions:Not disclosed
Scope 3 Emissions:Not disclosed
Renewable Energy Share:Not disclosed
Total Energy Consumption:Not disclosed
Water Consumption:Not disclosed
Waste Generated:Not disclosed
Carbon Intensity:Not disclosed

ESG Focus Areas

  • Not disclosed

Environmental Achievements

  • Not disclosed

Social Achievements

  • Not disclosed

Governance Achievements

  • Established a share buyback framework (12.07% of its issued shares).

Climate Goals & Targets

Long-term Goals:
  • Lay the foundations for sustainable growth in preparation for 2030.
Medium-term Goals:
  • Achieve a target ROIC of 6.8% (revised from 7.90%).
  • Increase contribution to community healthcare, targeting the elderly.
Short-term Goals:
  • Not disclosed

Environmental Challenges

  • Downward pressure on prices due to revisions to government-set drug prices and dispensing fees.
  • COVID-19 pandemic impact on prescription numbers and M&A activity.
  • Failure to meet requirements for the Tokyo Stock Exchange's Prime Market.
Mitigation Strategies
  • Focusing on capturing technical fees (community support system premiums and family pharmacist guidance fees).
  • Capital and business alliance with Suzuken Co., Ltd. to expand business.
  • Acquisition of GOOD AID to increase pharmacy network.
  • Investing in DX and building a system to earn premiums.

Supply Chain Management

Supplier Audits: Not disclosed

Responsible Procurement
  • Not disclosed

Climate-Related Risks & Opportunities

Physical Risks
  • Not disclosed
Transition Risks
  • Not disclosed
Opportunities
  • Not disclosed

Reporting Standards

Frameworks Used: Null

Certifications: Null

Third-party Assurance: Not disclosed

UN Sustainable Development Goals

  • Not disclosed

Not disclosed

Sustainable Products & Innovation

  • Not disclosed

Awards & Recognition

  • Not disclosed